4/A
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-22-036716
President & CEO gave up 3,675 shares (to pay taxes)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hirsch Andrew President & CEO | 2022-05-26 | Shares withheld for taxes | −3,675 | $7.01 | $25,762 | 18,825 | D |
Loading xslF345X03/doc4a.xml…